Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

NCT06032052 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Elderly Patients
Metastatic Lung Cancer

Interventions

DRUG: Single drug chemotherapy plus immunotherapy

Sponsor

Hubei Cancer Hospital